UnitedHealth is reeling from a nearly 20% stock rout after warning investors about its first revenue decline in decades

Core Viewpoint - UnitedHealth is experiencing a significant stock decline of approximately 20% following its warning of an expected annual revenue decrease for the first time in over 30 years, impacting its market value and the broader managed-care sector [1][2]. Financial Performance - The company reported fourth-quarter 2025 revenue of about $113.2 billion, reflecting a year-over-year increase of over 12%, but net income fell sharply to around $10 million, or 1 cent per share, due to $1.6 billion in after-tax restructuring charges [5]. - Adjusted earnings per share for the quarter were $2.11, aligning with forecasts but down significantly from $6.81 a year earlier, attributed to rising medical costs and other operational challenges [5]. Revenue Outlook - For full-year 2025, UnitedHealth anticipates revenue of approximately $447.6 billion, representing a 12% increase year-over-year, but projects a revenue decline of about 2% for 2026, with expectations of "greater than" $439 billion, falling short of analyst estimates of around $454 billion [2][3]. - The company aims for adjusted earnings per share of at least $17.75 for 2026, indicating high-single-digit profit growth despite the anticipated revenue dip [3]. Market Reaction - The stock market response was severe, with UnitedHealth shares dropping to around $282 from a previous close of approximately $352, marking one of the largest single-day declines in the company's history [4]. - This decline also negatively affected other major players in the Medicare Advantage sector, such as Humana, following disappointing proposals for government payment rates for 2027 [4]. Strategic Focus - UnitedHealth's executives emphasized the need for short-term sacrifices to reposition the business for future stability and growth, with plans to refocus on core markets and streamline operations under new leadership [6]. - The company expressed confidence in returning to growth in 2026, despite current challenges related to medical costs and care activity for new Medicare Advantage beneficiaries [6].